Suchergebnisse - "Clinical Trial, Phase III"

PubPharm (81)

1

GEM plus CDDP Combination Therapy for Unresectable Biliary Tract Cancer-A Single Institution Experience

enthalten in: Gan to kagaku ryoho. Cancer & chemotherapy | 2023

von Muneta, M. | Ohmura, Y. | Takeda, Y. | +12

2

Advanced Medical Care

enthalten in: Gan to kagaku ryoho. Cancer & chemotherapy | 2022

von Kenmotsu, H.

3

USEFULNESS OF RUPATADINE FOR PRURITUS OF PATIENTS WITH ATOPIC DERMATITIS

enthalten in: Arerugi = [Allergy | 2020

von Hide, M. | Hirata, K. | Komorita, N. | +4

4

EFFICACY, PHARMACOKINETICS, PHARMACODYNAMICS, AND SAFETY OF INTRAVENOUS C1 INHIBITOR FOR LONG-TERM PROPHYLAXIS AND TREATMENT OF BREAKTHROUGH ATTACKS IN JAPANESE SUBJECTS WITH HEREDITARY ANGIOEDEMA : A PHASE 3 OPEN-LABEL STUDY

enthalten in: Arerugi = [Allergy | 2020

von Fukunaga, A. | Morita, E. | Miyagi, T. | +8

5

A PHASE III STUDY TO EVALUATE SAFETY AND EFFICACY OF FLUTICASONE/FORMOTEROL COMBINATION (FLUTIFORM® AEROSOL) IN LONG-TERM ADMINISTRATION (24 WEEKS) IN JAPANESE PEDIATRIC PATIENTS WITH BRONCHIAL ASTHMA

enthalten in: Arerugi = [Allergy | 2020

von Katsunuma, T. | Kamata, M. | Ishikawa, Y.

6

Late phase II/III study of BYM338 in patients with sporadic inclusion body myositis (RESILIENT) : Japanese cohort data

enthalten in: Rinsho shinkeigaku = Clinical neurology | 2019

von Mori-Yoshimura, M. | Yamashita, S. | Suzuki, N. | +7

7

JETALS : The Japanese Early-stage Trial of high dose methylcobalamin for ALS

enthalten in: Brain and nerve = Shinkei kenkyu no shinpo | 2019

von Izumi, Y. | Oki, R. | Kuwabara, S. | +1

8

Pharmacological and clinical effects of letermovir (Prevymis®), a novel anti-human cytomegalovirus prophylactic drug

enthalten in: Nihon yakurigaku zasshi. Folia pharmacologica Japonica | 2019

von Ogawa, M. | Eto, T.

9

Pharmacological profiles and clinical effects of amenamevir tablet as treatments for herpes zoster

enthalten in: Nihon yakurigaku zasshi. Folia pharmacologica Japonica | 2019

von Maeda, H. | Nakamura, H. | Kikukawa, Y.

10

Preclinical and clinical properties of Bezlotoxumab (ZINPLAVA® 25 mg/mL concentrate for solution for infusion), novel therapeutic agent for Clostridium difficile infection

enthalten in: Nihon yakurigaku zasshi. Folia pharmacologica Japonica | 2018

von Kinoshita, K.

1
2
3
4
5
6
7
8
9
Nächster »
[9]